JPWO2020103859A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020103859A5 JPWO2020103859A5 JP2021529088A JP2021529088A JPWO2020103859A5 JP WO2020103859 A5 JPWO2020103859 A5 JP WO2020103859A5 JP 2021529088 A JP2021529088 A JP 2021529088A JP 2021529088 A JP2021529088 A JP 2021529088A JP WO2020103859 A5 JPWO2020103859 A5 JP WO2020103859A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- ferroptosis
- stereoisomer
- hydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000004806 ferroptosis Effects 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000017074 necrotic cell death Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018116555 | 2018-11-20 | ||
| CNPCT/CN2018/116555 | 2018-11-20 | ||
| PCT/CN2019/119676 WO2020103859A1 (fr) | 2018-11-20 | 2019-11-20 | Inhibiteurs de rip1 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022517902A JP2022517902A (ja) | 2022-03-11 |
| JPWO2020103859A5 true JPWO2020103859A5 (fr) | 2022-11-07 |
| JP7490647B2 JP7490647B2 (ja) | 2024-05-27 |
Family
ID=70773337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021529088A Active JP7490647B2 (ja) | 2018-11-20 | 2019-11-20 | Ｒｉｐ１阻害剤 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210284598A1 (fr) |
| EP (1) | EP3883918B1 (fr) |
| JP (1) | JP7490647B2 (fr) |
| KR (1) | KR20210108955A (fr) |
| CN (1) | CN113272272B (fr) |
| AU (1) | AU2019384283B2 (fr) |
| BR (1) | BR112021009723A2 (fr) |
| CA (1) | CA3120726C (fr) |
| CO (1) | CO2021006480A2 (fr) |
| IL (1) | IL283309B2 (fr) |
| MX (1) | MX2021005944A (fr) |
| SG (1) | SG11202105264UA (fr) |
| WO (1) | WO2020103859A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022194259A1 (fr) * | 2021-03-18 | 2022-09-22 | Sironax Ltd. | Inhibiteurs de protéine 1 interagissant avec le récepteur, préparations et utilisations de ceux-ci |
| WO2023066368A1 (fr) * | 2021-10-22 | 2023-04-27 | Sironax Ltd. | Formes cristallines d'inhibiteur de rip1 |
| US11541116B1 (en) | 2022-01-07 | 2023-01-03 | Kojin Therapeutics, Inc. | Methods and compositions for inducing ferroptosis in vivo |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4405357A (en) * | 1980-06-02 | 1983-09-20 | Fmc Corporation | Herbicidal 3-isoxazolidinones and hydroxamic acids |
| GB8820185D0 (en) * | 1988-08-25 | 1988-09-28 | Wellcome Found | New medical use |
| US6756394B1 (en) | 1999-10-15 | 2004-06-29 | President And Fellow Of Harvard College | Small molecule inhibitors of necrosis |
| US6706766B2 (en) | 1999-12-13 | 2004-03-16 | President And Fellows Of Harvard College | Small molecules used to increase cell death |
| ES2567135T3 (es) | 2003-08-29 | 2016-04-20 | The Brigham And Women's Hospital, Inc. | Derivados de hidantoína como inhibidores de necrosis celular |
| EP2192838A4 (fr) | 2007-08-15 | 2011-07-27 | Harvard College | Inhibiteurs hétérocycliques de la nécroptose |
| WO2010075290A1 (fr) | 2008-12-22 | 2010-07-01 | President And Fellows Of Harvard College | Inhibiteurs hétérocycliques insaturés de la nécroptose |
| BRPI0923126A2 (pt) | 2008-12-23 | 2021-09-08 | President And Fellows Of Harvard College | Compostos inibidores de molécula pequena de necroptose, uso e composição compreendendo os mesmos e método de diminuir necroptose |
| US9643977B2 (en) | 2011-03-11 | 2017-05-09 | President And Fellows Of Harvard College | Necroptosis inhibitors and methods of use therefor |
| CN107108539A (zh) * | 2014-09-15 | 2017-08-29 | 北京生命科学研究所 | 钠‑葡萄糖协同转运蛋白2(sglt‑2)抑制剂 |
| EP3224237A4 (fr) * | 2014-12-24 | 2018-02-07 | National Institute Of Biological Sciences, Beijing | Inhibiteurs de nécrose |
| EP3224245B1 (fr) | 2014-12-24 | 2018-09-12 | National Institute Of Biological Sciences, Beijing | Inhibiteurs de nécrose |
| WO2018192416A1 (fr) * | 2017-04-17 | 2018-10-25 | National Institute Of Biological Sciences, Beijing | Traitement de la sénescence masculine |
-
2019
- 2019-11-20 AU AU2019384283A patent/AU2019384283B2/en active Active
- 2019-11-20 MX MX2021005944A patent/MX2021005944A/es unknown
- 2019-11-20 CA CA3120726A patent/CA3120726C/fr active Active
- 2019-11-20 IL IL283309A patent/IL283309B2/en unknown
- 2019-11-20 CN CN201980087301.3A patent/CN113272272B/zh active Active
- 2019-11-20 SG SG11202105264UA patent/SG11202105264UA/en unknown
- 2019-11-20 WO PCT/CN2019/119676 patent/WO2020103859A1/fr unknown
- 2019-11-20 KR KR1020217018499A patent/KR20210108955A/ko active Search and Examination
- 2019-11-20 EP EP19887923.1A patent/EP3883918B1/fr active Active
- 2019-11-20 JP JP2021529088A patent/JP7490647B2/ja active Active
- 2019-11-20 BR BR112021009723-6A patent/BR112021009723A2/pt unknown
-
2021
- 2021-05-19 US US17/325,193 patent/US20210284598A1/en active Pending
- 2021-06-19 CO CONC2021/0006480A patent/CO2021006480A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021098728A5 (fr) | ||
| JP2023002662A5 (fr) | ||
| JP2022191257A5 (fr) | ||
| JP2017528507A5 (fr) | ||
| RU2561040C2 (ru) | Фармацевтические композиции для лечения воспалительных заболеваний кишечника (взк) | |
| JP2020508338A5 (fr) | ||
| JP2023076465A5 (fr) | ||
| JP2015510916A5 (fr) | ||
| JP2023166406A5 (fr) | ||
| JP2005507892A5 (fr) | ||
| JP2019536812A5 (fr) | ||
| JP2013507442A5 (fr) | ||
| JP2020534270A5 (fr) | ||
| JP2020529995A5 (fr) | ||
| JP2007520564A5 (fr) | ||
| JP2019218379A5 (fr) | ||
| EA202190544A1 (ru) | Применение распадающихся в полости рта таблеток рилузола для лечения заболеваний | |
| JP2010500284A5 (fr) | ||
| JP2008533079A5 (fr) | ||
| JP2019507786A5 (fr) | ||
| JPWO2020103859A5 (fr) | ||
| JP2003503453A5 (ja) | ガバペンチンおよびプレガバリンを含む相乗作用組成物 | |
| RU2010147881A (ru) | ФАРМАЦЕВТИЧЕСКИЙ ПРОДУКТ, СОДЕРЖАЩИЙ АНТАГОНИСТ МУСКАРИНОВОГО РЕЦЕПТОРА И АГОНИСТ β2-АДРЕНОРЕЦЕПТОРА | |
| JP2017514829A5 (fr) | ||
| WO2018163119A1 (fr) | Acide 1-pipéridinepropionique pour le traitement d'une maladie fibrosante |